Your Notifications
All done, no notifications

2 Specialists

Dr. Mohamed Sulaiman

Pediatric Cardiologist

, Dubai, United Arab Emirates

22 Years of experience

Speaks: Arabic , English

 

View Telemedicine Doctors

Dr. Mohamed Sulaiman is a specialized Pediatric Cardiologist in United Arab Emirates. And one of the most sought after medical specialists in Dubai, United Arab Emirates. The doctor has over 21 Years of experience and is associated with Kings College Hospital Dubai.

Association and Memberships Dr. Mohamed Sulaiman is part of:

  • Member of the American Academy of Pediatrics
  • Member of The American College of Cardiology

Qualifications :

  • Fellowship in Pediatric Cardiac MRI, Boston Children's Hospital, Harvard Medical School, USA, 2012.
  • Fellowship in Pediatric Cardiology, University of Illinois, USA, 2005 – 2008
  • Board Certified, American Board of Pediatrics (Pediatric Cardiology), University of Illinois, USA, 2008.
  • Board Certified, American Board of Pediatrics (General Pediatrics), Columbia University, USA, 2002.
  • Bachelor of Medicine and Pediatric Residency Sanaa University, Yemen 1995.
  • Member of the American Academy of Pediatrics.
  • Member of the American College of Cardiology.
  • Lead Instructor: PALS, NALS.

Hospital Address :

' -

What is the medical expertise of Dr Mohamed Sulaiman?

  • Dr Mohamed Sulaiman is a leading pediatric cardiologist with 21 years of experience in treating acquired and congenital heart diseases in both children and adults. He is proficient in stress testing, cardiac MRI, transthoracic echocardiography, fetal echocardiography, and transesophageal echocardiography.
  • He is a Fellow of the American College of Cardiology and certified by the American Board of Pediatrics. Dr Sulaiman also completed a Pediatric Cardiac MRI Fellowship at the Boston Children's Hospital, Harvard Medical School, USA.
  • Professionally, Dr Sulaiman is affiliated with noteworthy organizations such as the American College of Cardiology, the American Medical Association and the American Academy of Pediatrics.
  • He has several publications to his credit such as
    1. Alsamri MT, Hamdan MA, Sulaiman M, Narchi H, Souid AK. Hypoxia due to intrapulmonary vascular dilatation in a toddler with a congenital portacaval shunt: a case report. BMC Pulm Med. 2019 Feb 22;19(1):49.
View Profile
Dr. Ahmed Mohammed Al Kamali

Pediatric Cardiologist

, Sharjah, United Arab Emirates

26 Years of experience

Speaks: English , Arabic

 

View Telemedicine Doctors

Dr. Ahmed Mohammed Al Kamali is a specialized Pediatric Cardiologist in United Arab Emirates. And one of the most sought after medical specialists in Sharjah, United Arab Emirates. The doctor has over 26 Years of experience and is associated with NMC Royal Hospital Sharjah.

Association and Memberships Dr. Ahmed Mohammed Al Kamali is part of:

  • American Academy of Paediatrics

Certifications :

  • Fellowship in Paediatric Cardiology, Canada
  • Fellow of the American Academy of Paediatrics, USA

Qualifications :

  • Degree in Paediatrics, Ireland
  • American Board of Pediatrics
  • Canadian Board of Pediatrics

Hospital Address :

Al Zahra Hospital - Sharjah - United Arab Emirates

What is the medical expertise of Dr Ahmed Mohammed Al Kamali?

  • Dr Ahmed Mohammed Al Kamali is a respected pediatric cardiologist with 26 years of experience in the field. He has treated more than 1000 congenital heart disease cases. His areas of expertise include echocardiography, stenting, coarctation of the aorta, atrial septal defect and aortic valve stenosis.
  • Dr Kamali completed his Pediatric Fellowship at McMaster University, Canada, a Diploma in Child health at the Royal College of Physicians and Surgeons in Ireland and a Pediatric Cardiology Fellowship at the University of Ottawa in Canada.
  • He is a Diplomate of the American Board of Pediatrics and a Fellow of the American Academy of Pediatrics.
View Profile

Frequently Asked Questions

Do UAE hospitals offer advanced technology for PDA closure procedures?

Yes. Leading hospitals in the UAE are equipped with modern cardiac catheterisation labs and neonatal cardiac care units for minimally invasive PDA (Patent Ductus Arteriosus) closure. This includes both transcatheter closure using PDA occluder devices and surgical ligation in complex or premature cases. Key technologies include:

  • High-resolution echocardiography (2D/3D, TEE, ICE)
  • Dedicated paediatric and neonatal cath labs
  • FDA/CE-approved devices such as Amplatzer Duct Occluder
  • Advanced neonatal and paediatric ICU (NICU/PICU) support
  • Hybrid catheterisation–OR suites for high-risk cases

MediGence partners with these top-tier hospitals, providing trusted access to paediatric cardiology experts and fast-track PDA closure packages for newborns, children, and adults.

Do UAE cardiologists have experience with PDA closure procedures?

Yes. UAE paediatric cardiologists and interventional cardiologists regularly perform PDA closure procedures in both term and preterm infants, children, and select adults. They are guided by global clinical guidelines from:

  • American Heart Association (AHA)
  • European Association for Paediatric and Congenital Cardiology (AEPC)
  • Gulf Heart Association (GHA)

MediGence works exclusively with board-certified cardiologists who have specialised training and extensive experience in transcatheter PDA closure and congenital heart defect management.

What conditions require PDA closure?

Patent Ductus Arteriosus (PDA) is a congenital heart defect where a fetal blood vessel fails to close after birth. PDA closure is recommended in:

  • Infants with heart failure symptoms or poor growth
  • Moderate-to-large PDA with left heart enlargement or pulmonary hypertension
  • Premature babies with significant hemodynamic compromise
  • Adults with persistent PDA, murmur, or infective endocarditis risk
  • Children with recurrent respiratory infections or failure to thrive
  • Small, asymptomatic PDAs may be monitored, but many require closure to prevent long-term complications.
Can PDA closure cure the condition?

Yes. PDA closure—especially via catheter-based occluder devices—is curative in most patients. Key benefits include:

  • Elimination of abnormal blood flow between the aorta and the pulmonary artery
  • Resolution of symptoms such as fatigue, shortness of breath, and feeding difficulties
  • Prevention of complications like endocarditis, heart failure, and pulmonary hypertension
  • Normalisation of heart size and function
  • Minimally invasive with quick recovery and short hospital stay
  • Success rates for transcatheter PDA closure exceed 98%, with minimal risk of complications.
Is PDA closure available in the UAE for international patients?

Yes. The UAE is a sought-after destination for paediatric and adult congenital heart interventions like PDA closure. International patients benefit from:

  • Access to expert interventional cardiologists and paediatric heart teams
  • Rapid diagnosis and intervention—even for newborns and preterm infants
  • Support with medical visas, travel, translation, and family accommodation
  • Comprehensive NICU/PICU and recovery care
  • Coordination of post-op follow-up and rehabilitation

MediGence provides full-service international patient support, including pre-negotiated PDA closure packages and a personalised care team.

Can I consult with a UAE cardiologist online before travelling?

Yes. Through MediGence, you can schedule a teleconsultation with a UAE cardiologist to:

  • Review fetal or postnatal echocardiogram reports
  • Confirm the diagnosis and candidacy for transcatheter PDA closure
  • Discuss device options (e.g., Amplatzer, Occlutech, Nit-Occlud)
  • Receive a cost estimate, hospital stay plan, and recovery timeline
  • Clarify logistics, travel preparation, and pre-op requirements
  • Virtual consultations help you prepare thoroughly and minimise delays in time-sensitive cases.
What qualifications do UAE cardiologists have for PDA closure?

UAE paediatric and interventional cardiologists typically:

  • Hold board certifications in paediatric or adult cardiology and interventional cardiology
  • Are trained in leading international centres (USA, UK, Germany, India)
  • Are licensed by the Dubai Health Authority (DHA) or Department of Health (DoH – Abu Dhabi)
  • Have extensive experience with device closures for congenital defects, including PDA, ASD, and VSD

MediGence only lists verified, licensed specialists with high success rates in PDA closures and congenital heart procedures.

How can I verify the credibility of a UAE cardiologist for PDA closure?

You can verify a UAE cardiologist’s credibility by:

  • Searching their name on the DHA or DoH – Abu Dhabi registry
  • Reviewing their profiles and patient stories on the MediGence platform
  • Requesting their qualifications, training history, and procedural outcomes
  • Viewing testimonials from families who underwent PDA closure in the UAE

MediGence ensures all listed cardiologists are board-certified, licensed, and experienced, with transparent credentials.

What types of PDA closure devices are used in the UAE?

UAE hospitals use a range of globally approved PDA closure devices, tailored to the patient’s age and defect size. Common options include:

  • Amplatzer Duct Occluder I/II
  • Occlutech PDA Occluder
  • Lifetech Cera occluders
  • Nit-Occlud coils (for small PDAs)

The choice of device is based on the patient's PDA anatomy, weight, and associated conditions.

What is the recovery process after PDA closure?

The recovery process after transcatheter PDA closure is typically smooth and includes:

  • 12–24 hours of observation in a cardiac step-down or NICU setting
  • A short hospital stay (1–2 days for most patients)
  • Temporary medications to prevent clotting
  • Follow-up echocardiograms at 1, 3, and 6 months
  • Return to regular activity within a week (children and adults)
  • Guidance for infective endocarditis prevention during future surgeries

MediGence assists in organising follow-up schedules and coordinating second opinions if needed.